SCHEMBL2465313

SCHEMBL2465313

c1nc2cc(-c3cn[nH]c3)ccc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.54
ACVR1 Q04771 1/20 0.44
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
ALK Q9UM73 1/20 0.42
AKT1 P31749 1/20 0.42
AKT2 P31751 1/20 0.42
CLK2 P49760 5/20 0.40
HIPK1 Q86Z02 5/20 0.40
HIPK2 Q9H2X6 5/20 0.40
HIPK3 Q9H422 5/20 0.40
CLK4 Q9HAZ1 5/20 0.40
DYRK2 Q92630 3/20 0.40
CLK1 P49759 2/20 0.40
PIK3CD O00329 1/20 0.40
GRK2 P25098 1/20 0.39
GRK1 Q15835 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2461206 0.87 DYRK1A (0.54) DYRK1AACVR1PIM1PIM3PIM2
SCHEMBL28048555 0.82 DYRK1A (0.72) DYRK1ACLK2CLK4CLK1PIK3CD
SCHEMBL2457425 0.75 DYRK1A (0.55) DYRK1ACLK2CLK4CLK1PIK3CD
SCHEMBL2455181 0.74 PIM1 (0.43) DYRK1AACVR1PIM1PIM3PIM2
SCHEMBL592989 0.74 DYRK1A (0.62) DYRK1AALKPIK3CDMEN1ALDH1A1
SCHEMBL29375136 0.74 DYRK1A (0.62) DYRK1AALKPIK3CDMEN1ALDH1A1
SCHEMBL8076216 0.73 DYRK1A (0.60) DYRK1ACLK2CLK4CLK1PIK3CD
SCHEMBL8080835 0.73 DYRK1A (0.60) DYRK1ACLK2CLK4CLK1PIK3CD
SCHEMBL10337032 0.73 DYRK1A (0.60) DYRK1ACLK2CLK4CLK1PIK3CD
SCHEMBL27606654 0.73 DYRK1A (0.60) DYRK1APIK3CDMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET DYRK1A 4134/4885ACVR1 277/4885PIM1 1476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.